GRM5 and nervous system disorder: [18F]-FPEB has been developed by Merck Research Laboratories and, regarding its high specificity and selectivity for mGluR5, together with a suitable brain kinetics (218, 219), has been extensively used to investigate mGluR5 density in neurological disorders.